Visceral adipose tissue area predicts major adverse kidney events in patients with acute necrotizing pancreatitis

Abstract

BackgroundGiven the previously reported harmful effects of abdominal fat burden on kidney function, we aim to investigate the relationship between major adverse kidney events within 30 days (MAKE30) and abdominal obesity in acute necrotizing pancreatitis (ANP) patients and explore the underlying risk factors. MethodsA retrospective cohort study of all patients admitted within 72 h after the first episode of ANP to a tertiary center between June 2015 and June 2019 was conducted. Automatic image analysis software was used to calculate the area of subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and skeletal muscle from computed tomography scans at the umbilical level. The potential risk factors of MAKE30 were analyzed by logistic regression. ResultsA total of 208 eligible ANP patients were enrolled, with an incidence of 23 % for MAKE30. VAT area was more closely associated with the development of MAKE30, with an area under the ROC curve of 0.69 (cutoff value 200 cm2, 63.8 % sensitivity and 66.7 % specificity). Multivariate logistic regression analysis demonstrated that VAT area [OR 1.01 (1.01–1.02); p < 0.001] was an independent risk factor in predicting MAKE30. Patients with a VAT area > 200 cm2 had more requirements of renal replacement therapy (32% vs. 12 %, P < 0.001), and a significantly higher incidence of other poor clinical outcomes (all p < 0.05). ConclusionEarly assessment of the VAT area may help identify ANP patients at high risk of MAKE30, suggesting that it could be a potential indicator for adverse kidney events.